RAD51 and neoplasm: Depletion of RAD51 expression did not significantly reduce proliferation rates of the MDA-MB-231 cells in vitro (p=0.221) (Figure 4B) and primary tumour growth was not affected in vivo (Figure 4C), with no significant difference in proliferation as measured by immunostaining of Ki67 (Figure 4D).